Wall Street analyst estimates for BillionToOne, Inc. (BLLN): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection.
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2026-10-06 | $0.16 | ||
| 2026-08-05 | $0.15 | $0.18 | -18.2% |
| 2026-05-06 | $0.34 | $0.01 | +3300.0% |
| 2026-03-04 | $0.11 | $0.07 | +57.1% |
| 2025-12-09 | $0.10 | $0.14 | -28.3% |
| 2025-10-07 | $-0.02 | $0.14 | -114.3% |
Valuation Ratios
| P/E Ratio | 170.78 |
| Price / Book | 9.15 |
| EV / EBITDA | 88.89 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | $71.7M | $152.6M | $305.1M |
| Cost of Revenue | $54.4M | $71.7M | $96.7M |
| Gross Profit | $17.3M | $80.9M | $208.5M |
| Research & Development | $22.4M | $36.6M | $49.4M |
| Selling, General & Admin | $64.4M | $91.5M | $143.1M |
| Operating Expenses | $86.8M | $128.1M | $192.4M |
| Operating Income | -$69.5M | -$47.1M | $16.0M |
| EBITDA | -$72.9M | -$27.5M | $19.8M |
| Interest Expense | $3.3M | $2.4M | $95,000 |
| Pre-tax Income | -$82.7M | -$41.5M | $7.8M |
| Income Tax | $9,000 | $29,000 | $305,000 |
| Net Income | -$82.7M | -$41.6M | $7.5M |
| EPS | $-1.85 | $-0.93 | $0.06 |
| EPS (Diluted) | $-1.85 | $-0.93 | $0.06 |
| Shares Outstanding (Diluted) | $44.7M | $44.7M | $45.8M |
Price
| Price | $109.06 |
| Market Cap | $5.0B |
| Exchange | NASDAQ |
| Country | US |
Explore sector: Healthcare · Medical - Diagnostics & Research
More sections of BLLN: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks